|
Title
|
|
|
|
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
| |
|
Author
|
|
|
|
| |
|
Institution/Organisation
|
|
|
|
EADB Contributors
GR ACE Study Grp
DEGESCO Consortium
IGAP ADGC
CHARGE
EADI
GERAD
PGC-ALZ Consortia
| |
|
Abstract
|
|
|
|
| Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n=409,435 and validation size n=58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE 4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease. Known genetic loci account for only a fraction of the genetic contribution to Alzheimer's disease. Here, the authors have performed a large genome-wide meta-analysis comprising 409,435 individuals to discover 6 new loci and demonstrate the efficacy of an Alzheimer's disease polygenic risk score. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Nature communications
| |
|
Publication
|
|
|
|
2021
| |
|
ISSN
|
|
|
|
2041-1723
| |
|
DOI
|
|
|
|
10.1038/S41467-021-22491-8
| |
|
Volume/pages
|
|
|
|
12
:1
(2021)
, 16 p.
| |
|
Article Reference
|
|
|
|
3417
| |
|
ISI
|
|
|
|
000713875100002
| |
|
Pubmed ID
|
|
|
|
34099642
| |
|
Medium
|
|
|
|
E-only publicatie
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|